Bluepha Secures Round-B Financing of 1.5 Billion Yuan
Leading Chinese synthetic biology firm Bluepha announced today that it has completed a B3 round of financing, bringing total round-B funds to 1.5 billion yuan ($235 million).
Bluepha’s B3 round was jointly led by Genesis Capital and China State-owned Enterprises Mixed-ownership Reform Fund (Mixed Reform Fund), followed by Zhongping Capit…
Keep reading with a 7-day free trial
Subscribe to Pandaily to keep reading this post and get 7 days of free access to the full post archives.